Observational studyCritical care (London, England)2026
Autoregulation-guided intracranial pressure and cerebral perfusion pressure targets in different subtypes and characteristics of traumatic brain injury.
Observational study in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundConsidering the significant heterogeneity of traumatic brain injury (TBI), uniform treatment thresholds applied to all patients may be overly simplistic. Cerebral autoregulation (CA) capacity may vary significantly between TBI patients and may change dynamically over time. Within a precision neurointensive care framework, this study aimed to evaluated the associations between cerebral perfusion pressure (CPP) or intracranial pressure (ICP) and the pressure reactivity index (PRx) in patients with different types of TBI, and to investigated whether PRx modified the associations between ICP and CPP and functional outcome.
methodsA prospective observational study was performed. Eligible patients had acute TBI with ICP, and arterial blood pressure monitoring and available 6-month outcome data assessed using the Glasgow Outcome Scale–Extended (GOSE). During the first 7 days postinjury, we calculated the proportion of good monitoring time (%GMT) spent predefined thresholds. The %GMT within predefined cerebral physiological intervals of PRx in combination with ICP or CPP, in relation to outcome, was analyzed using two-variable heatmaps. The associations between PRx and ICP or CPP were further evaluated using generalized additive models (GAMs) with cubic splines.
resultsIn total, 187 patients requiring invasive neuromonitoring after TBI were included. PRx exhibited a U-shaped relationship with CPP, with the optimal PRx observed at a CPP of 70–80 mmHg. In the PRx–ICP heatmap, the combination of elevated PRx and high ICP was significantly associated with worse outcomes. In the PRx–CPP heatmap, outcomes worsened when CPP decreased and PRx deviated from 0. Lower CPP appeared better tolerated in patients with preserved autoregulation, as indicated by lower PRx values. Patients without decompressive craniectomy (DC), with diffuse injury or younger age demonstrated better tolerance to lower CPP when autoregulatory function was preserved compared to patients with DC, focal injury or older age. When all physiological variables were incorporated into a single multivariable model, only composite variable 2 remained independently associated with favorable outcome (odds ratio [OR] 1.026, 95% confidence interval [CI] 1.006–1.046, P = 0.012).
conclusionsThis study provides novel insights into cerebral physiology across various TBI subtypes by delineating safe and hazardous thresholds for ICP, PRx, and CPP. The acceptable lower limit of CPP appears to be directly proportional to the PRx. Consequently, patients with severe impairment of CA may require higher CPP targets to achieve favorable outcomes. These findings emphasize the importance of individualizing target CPP based on PRx dynamics rather than relying on universally applied empirical thresholds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.